Clinical Trial Update: Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP) [Phase 1]

View source ↗

Summary

A Phase 1 trial sponsored by Rockefeller University evaluating diphenylcyclopropenone for cutaneous metastases of melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Diphenylcyclopropenone (diphenylcyclopropenone)

Snippet

Sponsor: Rockefeller University | Conditions: Neoplasm Metastasis, Melanoma | Phase 1 | Status: COMPLETED